Sizeable investments in leading Life Science companies

What we do

We invest in life science companies whose key sources of value creation are innovation and growth. Our investments come with an engaged and supportive approach to help a company, its board and its management realize their full potential.

Our investment approach

The Principal Investment team targets investments in well-established life science companies with leading positions in attractive market segments and strong underlying growth drivers. Principal Investments operates out of Denmark (Copenhagen), the UK (London) and the US (Boston), investing in privately owned and publicly listed companies with a mix of control, co-control and minority positions. Novo Holdings’ Asia investment team, based in Singapore, works in close collaboration with our teams in Europe and the US. We look to invest USD 100-500+ million in each transaction, always with an engaged, supportive ownership agenda in mind.

In addition to capital and engagement, an investment from Novo Holdings also provides access to our extensive network within the life science industry. We use our experience and expertise from our ownership of world-leading life science companies to actively support a board and management in realizing their strategic ambitions.

At the end of 2022, the Principal Investments portfolio comprised 24 companies, with a total value of EUR 10 billion.

All teams

Meet our team

Our team consists of highly skilled professionals with a diverse set of backgrounds including industry, consulting, banking and private equity. We use our life science expertise to target long-term investment opportunities.

  • 10 bn

    Value of investments at the end of 2022

  • 24

    Portfolio companies in 2022

  • 1,5 bn

    Deployed in 2022

Our headquarters

The Principal Investments team is based at our headquarters in Copenhagen, Denmark.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
+45 3527 6500
CVR# 24257630

Principal Investments*
200 Clarendon Street, Floor 45
Boston, MA 02116

*) Principal Investments is a team of business professionals employed by Novo Holdings Equity US Inc., which is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.